Octavio Espinoza
Chief Financial Officer · LIGAND PHARMACEUTICALS INC
- 2024
- Aug 14, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Octavio Espinoza files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
- Nancy Ryan Gray - $1.35M in LGND purchases and sales in the last 12 months
- Jason Aryeh - $1.25M in LGND purchases and sales in the last 12 months
- Stephen L. Sabba - $1.16M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Octavio Espinoza?
Octavio Espinoza is a corporate insider, tracked as Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Octavio Espinoza submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Octavio Espinoza been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($13.28M) across all tracked filings.
